Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer


In developed countries, ovarian cancer is the fourth most common cancer in women. Due to the non-specific symptomatology associated with the disease many patients with ovarian cancer are diagnosed late, which leads to significantly poorer prognosis. Apart from surgery and radiotherapy, a substantial number of ovarian cancer patients will undergo… (More)
DOI: 10.1007/s00432-015-2064-5


5 Figures and Tables

Slides referencing similar topics